Trial Profile
T Cell Responses to Varicella Zoster Virus After Vaccination and Viral Escape
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Apr 2017
Price :
$35
*
At a glance
- Drugs Varicella zoster virus vaccine live (Primary)
- Indications Varicella zoster virus infections
- Focus Pharmacodynamics
- 11 Jan 2017 Time frame of primary endpoint has been changed from Day 0 to Day 28 to Day 0 to Day 35. primary end point and treatment also amended.
- 11 Jan 2017 Status changed from active, no longer recruiting to completed.
- 22 Aug 2013 New trial record